allylamine has been researched along with Stroke in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, J; Qian, C; St Peter, WL; Ye, X | 1 |
Robinson, JG | 1 |
Chen, W; Khatibi, NH; Ma, Q; Manaenko, A; Tang, J; Zhang, JH | 1 |
1 review(s) available for allylamine and Stroke
Article | Year |
---|---|
LDL reduction: how low should we go and is it safe?
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Muscular Diseases; Niacin; Risk Factors; Stroke | 2008 |
2 other study(ies) available for allylamine and Stroke
Article | Year |
---|---|
Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
Topics: Age Factors; Aged; Allylamine; Anticholesteremic Agents; Cohort Studies; Colesevelam Hydrochloride; Databases, Factual; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Hospitalization; Humans; Hyperlipidemias; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk Factors; Sex Factors; Stroke; Treatment Outcome | 2013 |
Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice.
Topics: Allylamine; Amine Oxidase (Copper-Containing); Animals; Behavior, Animal; Brain Edema; Cell Adhesion Molecules; Chemokine CCL2; Down-Regulation; Gene Silencing; Humans; Inflammation; Injections, Intraperitoneal; Injections, Intraventricular; Intercellular Adhesion Molecule-1; Intracranial Hemorrhages; Male; Mice; Mice, Inbred Strains; Nervous System; Neutrophil Infiltration; Recombinant Proteins; RNA, Small Interfering; Semicarbazides; Stroke; Tumor Necrosis Factor-alpha | 2011 |